The Enterprise Value as of December 2025 (TTM) for Syncom Formulations (India) Limited (SYNCOMF.NS) is 14.23B

According to Syncom Formulations (India) Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 14.23B. This represents a change of -15.36% compared to the average of 16.81B of the last 4 quarters.

Syncom Formulations (India) Limited (SYNCOMF.NS) Historical Enterprise Value (quarterly & annually)

How has SYNCOMF.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Syncom Formulations (India) Limited over the last ten years is 7.77B. The current 14.23B Enterprise Value has changed 18.21% with respect to the historical average. Over the past ten years (40 quarters), SYNCOMF.NS's Enterprise Value was at its highest in in the March 2025 quarter at 18.96B. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.

Syncom Formulations (India) Limited (SYNCOMF.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Syncom Formulations (India) Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syncom Formulations (India) Limited (SYNCOMF.NS) Average Enterprise Value

How has SYNCOMF.NS Enterprise Value performed in the past?

The current Enterprise Value of Syncom Formulations (India) Limited (SYNCOMF.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Syncom Formulations (India) Limited (SYNCOMF.NS) Enterprise Value vs. Peers

How is SYNCOMF.NS’s Enterprise Value compared to its peers?

Syncom Formulations (India) Limited’s Enterprise Value is greater than Jagsonpal Pharmaceuticals Limited (13.86B), less than Bajaj HealthCare Limited (15.49B), greater than Jagsonpal Pharmaceuticals Limited (13.86B), less than Bajaj HealthCare Limited (15.49B), less than Bliss GVS Pharma Limited (16.67B), less than Bliss GVS Pharma Limited (16.67B), less than Megasoft Limited (14.39B), greater than Hester Biosciences Limited (14.07B), greater than Hester Biosciences Limited (14.07B), greater than TTK Healthcare Limited (9.61B),

Build a custom stock screener for Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syncom Formulations (India) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syncom Formulations (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.